According to S&P, the average fee on Australian equities was 0.59% (annualised) in July. That's about $8m revenue across the market. Note that borrow fees are skewed by "specials", think of stocks that are in very high demand, like a Gamestop or whatever. You'll also find that the borrower must lodge collateral with their lender and the lender can earn interest on cash collateral or loan fees if it subsequently lends out the collateral stock.
So for a typical stock loan that is completely collateralised with cash, you'd be up for paying around 0.5% p.a in most stocks and give over your cash that you could have earned the cash rate on. Retail punters shorting things via CFD might want to ponder on the implied borrow cost on their short positions and how much their provider is making off them (sorry off-topic).
K2M got it right in that long term asset owners are happy to lend out stock and pick up a small tailwind of return because they are going to hold anyway.
No to the last question.
- Forums
- ASX - By Stock
- PNV
- Short Activity in PNV
Short Activity in PNV, page-6134
-
- There are more pages in this discussion • 725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.43 |
Change
-0.040(1.62%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$2.48 | $2.51 | $2.43 | $1.692M | 690.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 19941 | $2.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.45 | 4032 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 19941 | 2.430 |
1 | 6170 | 2.420 |
8 | 35200 | 2.410 |
7 | 9242 | 2.400 |
6 | 27475 | 2.390 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 4032 | 3 |
2.460 | 10716 | 5 |
2.470 | 8108 | 2 |
2.480 | 11160 | 4 |
2.490 | 14138 | 3 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
NEWS
Gold nuggets unearthed at Comet Well ahead of drilling! Discoveries continue as exploration ramps up
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
PNV (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online